Cart
sales@molnova.com
CL264
CAS No. 1510712-69-2
CL264( —— )
Catalog No. M26120 CAS No. 1510712-69-2
CL264, a specific agonist of TLR7, is used for innate immune signals research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 295 | Get Quote |
|
| 10MG | 507 | Get Quote |
|
| 25MG | 802 | Get Quote |
|
| 50MG | 1107 | Get Quote |
|
| 100MG | 1503 | Get Quote |
|
| 500MG | 3015 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCL264
-
NoteResearch use only, not for human use.
-
Brief DescriptionCL264, a specific agonist of TLR7, is used for innate immune signals research.
-
DescriptionCL264, a specific agonist of TLR7, is used for innate immune signals research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1510712-69-2
-
Formula Weight413.438
-
Molecular FormulaC19H23N7O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (60.47 mM)
-
SMILESCCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(cc3)C(=O)NCC(O)=O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.William CraigStagner, et al. Chapter Five - Sucrose octaacetate. Profiles of Drug Substances, Excipients and Related Methodology. Volume 44, 2019, Pages 267-291.
molnova catalog
related products
-
Tomaralimab
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2, used to study myelodysplastic syndromes (MDS).
-
BMS-378806
BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.
-
CEP-40783
CEP-40783 is an effective, specific and orally active AXL/c-Met inhibitor (IC50: 7/12 nM). It also inhibits MER and TYRO3 (IC50: 29/19 nM).
